Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
NCT06905561Recruiting
- Sponsor
- Second Affiliated Hospital of Hainan Medical University
- Start
- Feb 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in radiation-induced dermatitis (RID) comparing Treatment group (diclofenac sodium gel) with Control group (Placebo Comparator) (2 arms). Primary endpoint: Incidence of development of grade >= 2 Radiation-induced Dermatitis. Started Feb 2025; status: recruiting.
02
Drugs
diclofenac
03
Conditions
radiation-induced dermatitis (RID)
Beyond the preview
Go deeper on NCT06905561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905561.